The emergence of bone as an endocrine regulator has prompted a re-evaluation of the role of bone mineralization factors in the development of metabolic disease. Ectonucleotide pyrophosphatase/phosphodiesterase-1 (NPP1) controls bone mineralization through the generation of pyrophosphate and is elevated in dermal fibroblast cultures and muscle of patients with insulin resistance. We investigated the metabolic phenotype associated with impaired bone metabolism in mice lacking the NPP1 gene (Enpp1 -/-mice). Enpp1 -/-mice exhibited mildly improved glucose homeostasis on a normal diet but showed a pronounced resistance to obesity and insulin resistance in response to chronic high fat feeding. Enpp1
Introduction
Bone remodelling is a highly conserved and regulated process that controls bone homeostasis and maintains skeletal structural integrity. This vital function is characterized by alternating phases of bone resorption by osteoclasts and bone formation by osteoblasts, and has a high energetic cost (Ducy et al., 2000) . 
Results

Enpp1 -/-mice show unaltered fat mass on control diet
There was no significant difference in body weight gain from 4 weeks of age between WT and Enpp1 -/-mice (Fig. 1A ), yet a significant reduction in quadratus femoris muscle mass was observed from 4 weeks of age in Enpp1 -/-mice (12%; P<0.05; Fig. 1B ) with no differences in soleus muscle (Fig. 1C) . The loss of muscle mass in the quadratus femoris, a key target of exercise loading, is a likely consequence of the debilitating arthritis that the
Enpp1
-/-mice exhibit (Filippin et al., 2013) . No effect of genotype on food intake was noted.
To assess onset and severity of arthritis, stride length was assessed using walking gait analysis. From 6 weeks of age, the stride length of the Enpp1 -/-mice was significantly reduced (P<0.05), as was the progressive increase in stride length with advancing age (Fig. 1D ). No differences in mRNA expression of muscle genes such as Mstn, Fbxo32 or Fndc5
were noted in these muscles (data not shown).
There were no differences in white (gonadal, subcutaneous and mesenteric) or brown fat mass ( Fig. 1E ) and no changes in mRNA levels of key genes for adipogenesis (Pparg), lipolysis (Prkaa20), mitochondrial metabolism (Cpt1a) or glucose transport (Slc2a4) in gonadal or brown fat mass (data not shown). However, Cpt1a and Slc2a4 mRNA expression in the subcutaneous fat mass was significantly reduced in Enpp1 -/-mice (50%; P<0.05; Fig.   1F ).
Chronic deficiency of NPP1 in mice induces insulin sensitization on control diet.
Due to the recognized inhibitory activity of NPP1 on the insulin receptor (Maddux et al.,
2000)
, we tested whether global deletion of Enpp1 would translate into changes in whole body glucose metabolism. Adult Enpp1 -/-mice showed normal glucose tolerance tests (GTT) ( Fig. 2A,D) but with a lower glucose-stimulated insulin secretion (GSIS) peak across the GTT indicating insulin sensitization (Fig. 2B,D) . Adult Enpp1 -/-mice also showed normal insulin tolerance tests (ITT) (Fig. 2C,D ) and there were no differences in insulin secreting islet size or number in the pancreas of Enpp1 -/-mice ( Fig. 4 E, F ).
Enpp1
-/-mice show obesity-resistance and improved insulin tolerance in response to chronic high fat diet challenge.
-/-mice showed resistance to weight gain caused by chronic high fat feeding compared to WT mice (Fig. 3A,B) . Of note, quadratus femoris mass increased with HF diet in the
-/-mice (40% increase compared to control diet; P<0.05), whereas walking gait, as denoted by stride length, remained significantly reduced (P<0.05) (Fig. 3C ).
-/-mice showed reduced white adipose tissue (WAT) mass (P<0.01; Fig. 3D ) and adipocyte cell diameter (Fig 3E) . Conversely, a marked increase in brown fat mass (37%; P<0.001; Fig. 3F ) was noted. The gonadal fat pad showed a significant increase in PGC1α
and Fndc5 (Fig. 3H) , which are indicative of increased mitochondrial biogenesis. However there was no change in Ucp1 mRNA levels ( Fig. 3H ) and hence no evidence for increased canonical thermogenesis or white fat browning as a mechanism underlying the reduced adiposity and improved metabolic profiles. In WAT, expression of white fat markers (e.g.
Cpt1
; Prkaa2) remained unaltered with HF diet (Fig. 3G-H Glucose tolerance was comparable between genotypes (Fig. 4A,D ). However, the insulin level (GSIS) across the GTT was lower in Enpp1 -/-mice, indicating potential insulin sensitization (Fig. 4B,D) . Improved Enpp1 -/-insulin sensitivity was confirmed by an insulin tolerance test (Fig. 4C,D) . Compared to wild type control mice, no significant differences in insulin secreting islet size or number in the pancreas of Enpp1 -/-mice were observed (Fig. 4 E, F).
Do osteoblasts regulate insulin sensitivity in the Enpp1 -/-mice?
Given that NPP1 is a negative regulator of insulin signaling, we investigated whether osteoblast insulin signaling might link NPP1 deficiency and improved whole glucose homeostasis. Initially, we considered the distribution (Fig. 5A ) and mRNA expression ( Fig   5B) of the insulin receptor in confluent monolayers of primary calvarial osteoblasts, with no effect of genotype observed. Furthermore there was no effect of NPP1 deletion on insulinstimulated Akt, Erk1/2 or GSK3β phosphorylation between Enpp1 -/-and WT primary calvarial osteoblasts cultured in vitro (Fig. 5C ). However, at 12 weeks of age Enpp1 -/-mice exhibited increased concentrations of the osteoblast-derived insulin sensitizing hormone undercarboxylated (GLU13) (119%, P<0.05; Fig. 5D ) and uncarboxylated (GLU) (156%, P<0.05; Fig. 5E ) osteocalcin, while carboxylated (GLA13) and total osteocalcin levels were comparable to WT (Fig. 5F,G) . Additionally, the degree of osteoblast and osteoclast activity was assessed by ELISA analysis of serum from Enpp1 -/-and WT mice. No changes in the bone formation marker P1NP were noted (Fig. 5H) , whereas a significant increase in the bone resorption marker CTx was observed in Enpp1 -/-mice compared to WT controls (P<0.05; Fig.   5I ). Together these data suggest that the increase in undercarboxylated osteocalcin detected in
Enpp1
-/-mice as a result of increased bone resorption may induce the altered insulin sensitivity phenotype observed.
Chronic high fat diet challenge induces brittle bone formation in WT mice and exacerbates the bone phenotype of Enpp1 -/-mice.
Given the detrimental effects of obesity on bone (Leslie et al., 2012), we next considered the effects of chronic high fat challenge on the bone physiology of the Enpp1 -/-mouse.
Following a chronic high fat diet challenge, trabecular bone in WT mice showed a significantly altered microarchitecture resulting in thinner and more disorganized trabeculi, compared with mice reared on a control diet (Table 1) . Cortical bone in WT mice fed a high fat diet showed a significantly increased bone mineral density compared with mice reared on a control diet (BMD; P<0.01). However, cortical thickness was unchanged by the high fat diet resulting in a more brittle bone as determined by the significantly decreased work to fracture (P<0.05) and post-failure work (P<0.05) observed in the three point bending analysis (Table 1) .
-/-mice displayed a significant deterioration of the already compromised trabecular architecture following a chronic high fat diet challenge, as exemplified by the significant loss of connectivity indicated by the trabecular pattern factor, the loss of trabecular bone as measured by percentage of bone volume (BV/TV) and the reduced trabecular organization when compared to control diet mice (Table 1 and Fig. 6A-D) . The tibiae of Enpp1 -/-mice displayed a significantly reduced cortical thickness (10%; P<0.01). This also translated into a weaker, more brittle bone as measured by three point bending parameters whereby the work to fracture and post-failure was significantly reduced by 34% and 50% respectively (P<0.05; Table 1 ). A high fat diet challenge also induced a significant decrease in bone modelling in
-/-mice, as indicated by the significant reduction in P1NP as a marker of bone formation (38%; P<0.001; Fig. 6E ) and CTX as a marker of bone resorption (20%; P<0.001; Fig. 6F ). These unique data highlight that a chronic high fat challenge has critical effects on the severity of the Enpp1 -/-bone phenotype.
Discussion
The role of NPP1 in controlling the pace of bone mineralization has been firmly established through the study of in vivo mouse models. This enzyme is crucial for the regulation of bone mineralization through the generation of PPi from nucleotide precursors. Enpp1 -/-mice display a distinct phenotype, including altered long bone and calvarial mineralization, and protecting against obesity and diabetes (Fig. 7) . A fuller understanding of the pathways of NPP1 may inform the development of novel therapeutic strategies for treating insulin resistance.
Materials and Methods
Animal model
The generation and characterization of germline 
Glucose and Insulin tolerance tests
Juvenile and adult (6 and 16 week old respectively) male mice were fasted for 4 hours and Animals were subsequently sacrificed at 7 and 18 weeks of age respectively to allow for recovery from the tests. Tissues including pancreas, liver, quadratus femoris, soleus muscle and tibiae as well as brown, subcutaneous, mesenteric and gonadal fat pads were collected for histological assessment and gene expression analysis.
Primary osteoblast cell culture
Primary osteoblasts (pOBs) were isolated the calvariae of 3-5 day-old wild-type (WT) and gentamicin (Invitrogen). Cells were maintained in 95% air/5% CO 2 at 37°C.
Cell signaling immunoblotting
Following confluency, pOBs were cultured for 24 hours in serum free medium containing 0.1% bovine serum albumin (BSA). Cells were then either lyzed immediately or stimulated with insulin (10 nM; Sigma) or IGF-I (10 nM; Sigma) for 10 minutes before lysis. Cells were lysed in RIPA buffer (Invitrogen) containing "phosphatase inhibitor cocktail 2" (Sigma) and "complete" protease inhibitor cocktail (Roche) according to manufacturers' instructions.
Immunoblotting with specific antibodies against phospho-Akt ser473 , total Akt, phospho- Table S1 ).
Tissue histology and cell immunofluorescence
Dissected tissues were fixed in 4% paraformaldehyde (PFA) or 10% phosphate buffered formalin (pH 7.4) and embedded in paraffin wax. 5 µm sections were stained with haematoxylin and eosin (H&E). Fresh tissues for lipid staining were collected immediately after euthanasia, snap frozen in precooled isopentane and stored at -80°C for less than 1 
Measurement of islet number and size
Serial sections were cut through each pancreas at 100µm intervals, stained with H&E and scanned with a Nikon CoolScan V (Nikon, Surrey, UK). The total area of a stained pancreas section was measured along with the number and size of the islets in that section using
ImageJ software (Wayne Rasband, National Institute of Health, USA). At least five randomly selected serial sections were examined per pancreas and three mice were analyzed for each diet/genotype group.
Micro-computed tomography (µCt) and mechanical testing of tibiae
Tibiae were dissected and immediately frozen in PBS at -20°C pending analysis. High resolution scans with an isotropic voxel size of 5 µm were acquired with a micro-computed tomography system (µCT, 60 kV, 0.5 mm aluminium filter, 0.6 ° rotation, Skyscan 1172, Brukker microCT, Kontich, Belgium). Scans were reconstructed using NRecon software (Brukker microCT). For each bone, a 1000 µm section of the metaphysis was taken for analysis of trabecular bone, using the base of the growth plate as a standard reference point.
A further 1500 µm below the base of the metaphysis section a 400 µm section of the middiaphysis was scanned for analysis of cortical structure. Data was analyzed with CtAn software (Brukker microCT). Cortical porosity was measured in the 2D slice by slice analysis. Binarized objects were identified containing fully enclosed spaces, and porosity was calculated as the area of those spaces as a percent of the total area of binarized objects. It should be noted that for this study, total porosity is a measurement of all of the space within the cortical bone not filled by mineral e.g. a blood vessel canal, a large osteocyte lacuna or a crack. Mechanical testing of the cortical bone was assessed by 3 point bending analysis using a Zwick materials testing machine (Zwick A.G., Ulm, Germany) with a 50 N loading cell, where the span was set at 5.5 mm and the cross-head speed was set at 1mm/min. Data was analyzed as previously described (Huesa et al., 2011).
Serum measurements
Immediately following euthanasia, blood was obtained from non-fasted 6 and 12 week old male mice and serum samples prepared. Total, carboxylated (GLA), undercarboxylated (GLU13-OCN) and uncarboxylated (GLU) osteocalcin was measured as previously described (Ferron et al., 2010) , as well as markers of bone formation (P1NP; IDS, Boldon, UK) and resorption (Ctx; IDS). 
Statistics
Standard comparisons between WT and
Results:
This research investigated the association of the metabolic phenotype and impaired bone metabolism in mice lacking the NPP1 gene (Enpp1 -/-mice). The authors provide new evidence that Enpp1 -/-mice showed a pronounced resistance to obesity and insulin resistance in response to chronic high fat feeding. Furthermore, the authors show that Enpp1 -/-mice had increased levels of the insulin sensitising bone-derived hormone osteocalcin, although insulin signaling remains unchanged within osteoblasts.
Implications and future directions:
These findings shed more light on the important role of NPP1 in the development of obesity and type 2 diabetes and provide information on the mechanism by which this protein regulates insulin sensitivity. A fuller understanding of the pathways of NPP1 may inform the development of novel therapeutic strategies for treating insulin resistance. 
